Halma strengthens its ophthalmic capabilities with bolt-on acquisition for MST
13 April 2026
Halma plc, the global group of life-saving technology companies, today announces that it has acquired Surgistar, Inc. (Surgistar), a US-based manufacturer of ophthalmic instruments and devices as a bolt on for its Healthcare Sector company, MicroSurgical Technology, Inc. (MST).
Founded in California over 20 years ago, Surgistar is a manufacturer of high quality surgical instruments and devices used in everyday ophthalmic procedures. It has built a strong reputation for product quality, reliable performance and long standing customer relationships. Surgistar designs instruments that perform reliably every time, helping clinicians work with confidence in situations where accuracy matters and supporting safer, more efficient care for patients.
Marc Ronchetti, Group Chief Executive of Halma, commented:
“Cataract and ophthalmic surgery are long term growth markets for Halma, supported by ageing populations and rising demand for eye procedures. Surgistar’s differentiated product range is highly complementary to MST’s, strengthening its position by adding products used in routine cataract surgery and expanding in house manufacturing capability. We are delighted to welcome Surgistar to MST and the Halma Group.”
For further information, please contact:
MHP
Oliver Hughes / Rachel Farrington / Ollie Hoare +44 (0)7817 458 804 [email protected]
A copy of this announcement, together with other information about Halma, may be viewed on our website www.halma.com.
About Surgistar
Surgistar is a California based manufacturer of ophthalmic surgical instruments, supplying eye care professionals worldwide. The company is known for its strong brand, high quality products and highly automated manufacturing capabilities, which support consistent performance and reliability across its portfolio.
For more information: https://surgistar.com
About MST
MST, headquartered in Redmond, Washington, USA, designs and manufactures high precision surgical instruments, with a particular focus on ophthalmic solutions that help restore and improve patients’ sight. As part of Halma’s Healthcare Sector, MST combines deep technical expertise with focused investment, global reach and a strong culture of innovation.
About Halma
Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day. Its purpose defines the three broad market areas where it operates:
- Safety: Protecting the safety of people and assets as populations grow and the demand on infrastructure increases.
- Environment: Addressing the impacts of climate change, pollution and waste, protecting life-critical resources and supporting scientific research.
- Health: Meeting the increasing demand for better healthcare as chronic illness rises, driven by growing and ageing populations and lifestyle changes.
Halma employs over 9,000 people in more than 20 countries, with major operations in the UK, Mainland Europe, the USA and Asia Pacific. Halma is listed on the London Stock Exchange (LON: HLMA) and is a constituent of the FTSE 100 index.
Halma has been named as one of Britain’s Most Admired Companies for the past seven years.
